Incontinence-Associated Dermatitis: An Insidious and Painful Condition

Babino, Graziella; Argenziano, Giuseppe

doi:10.1007/978-3-031-08392-1_21

Cited by 2 publications

(2 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of IAD varies across different settings and populations, from 5.2% to 46%. 4 , 11 , 12 While incontinence is a fundamental prerequisite for the development of IAD, not all incontinent individuals develop this condition, 13 suggesting that individual susceptibility varies.…”

Section: Introductionmentioning

confidence: 99%

Prognostic factors for the development of incontinence‐associated dermatitis (IAD): A systematic review

Deprez,

Ohde,

Eilegård Wallin

et al. 2024

International Wound Journal

View full text Add to dashboard Cite

Incontinence‐associated dermatitis (IAD) is an irritant contact dermatitis from prolonged contact with urine or faeces, which can significantly impact patient comfort and quality of life. The identification of prognostic factors for the development of IAD has the potential to enhance management, support preventive measures and guide future research. The objective of this systematic review was to summarize the empirical evidence of prognostic factors for the development of IAD. This study included prospective and retrospective observational studies or clinical trials that described prognostic factors associated with IAD. There were no restrictions on setting, time, language, participants or geographical regions. Exclusion criteria included reviews, editorials, commentaries, methodological articles, letters to the editor, cross‐sectional and case–control studies, and case reports. Searches were conducted from inception to April 2024 on MEDLINE, CINAHL, EMBASE and the Cochrane Library. The studies were assessed by two independent reviewers using the QUIPS and the CHARMS‐PF for data extraction. A narrative synthesis approach was employed due to study heterogeneity and using the ‘vote counting based on direction’ method and the sign test. The overall certainty of evidence was assessed using adapted GRADE criteria. The review included 12 studies and identified 15 potential predictors. Moderate‐quality evidence suggests that increased stool frequency, limited mobility and friction/shear problems are risk factors for IAD development. Female sex, older age, vasopressor use and loose/liquid stool are risk factors supported by low‐quality evidence. Increased stool frequency, limited mobility and friction/shear problems seem to be risk factors for the development of IAD. There is insufficient evidence to support the predictive validity of female sex, older age, loose/liquid stool and vasopressor use. There is substantial methodological variability across studies, making it challenging to make comparisons. Large‐scale cohort studies in different settings that incorporate our review findings should be conducted in the future.

show abstract

Section: Introductionmentioning

confidence: 99%

Prognostic factors for the development of incontinence‐associated dermatitis (IAD): A systematic review

Deprez,

Ohde,

Eilegård Wallin

et al. 2024

International Wound Journal

View full text Add to dashboard Cite

show abstract

“…Prevalence ranges between 5.2% and 46%, depending on the type of setting and population under study 9 12…”

Section: Introductionmentioning

confidence: 99%

What are the prognostic factors for the development of incontinence-associated dermatitis (IAD): a protocol for a systematic review and meta-analysis

Deprez,

Kottner,

Eilegård Wallin

et al. 2023

BMJ Open

View full text Add to dashboard Cite

IntroductionIncontinence-associated dermatitis (IAD) is irritant contact dermatitis and skin damage associated with prolonged skin contact with urine and/or faeces. Identifying prognostic factors for the development of IAD may improve management, facilitate prevention and inform future research.Methods and analysisThis protocol follows the guidelines of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols. Prospective and retrospective observational studies or clinical trials in which prognostic factors associated with the development of IAD are described are eligible. There are no restrictions on study setting, time, language, participant characteristics or geographical regions. Reviews, editorials, commentaries, methodological articles, letters to the editor, cross-sectional and case–control studies, and case reports are excluded. MEDLINE, CINAHL, EMBASE and The Cochrane Library will be searched from inception until May 2023. Two independent reviewers will independently evaluate studies. The Quality in Prognostic Studies tool will be used to assess the risk of bias, and the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies-Prognostic Factors checklist will be used for data extraction of the included studies. Separate analyses will be conducted for each identified prognostic factor, with adjusted and unadjusted estimated measures analysed separately. Evidence will be summarised with a meta-analysis when possible, and narratively otherwise. The Q and I2statistics will be calculated in order to quantify heterogeneity. The quality of the evidence obtained will be evaluated according to the Grades of Recommendation Assessment, Development and Evaluation guidance.Ethics and disseminationNo ethical approval is needed since all data is already publicly accessible. The results of this work will be published in a peer-reviewed scientific journal.

show abstract

Incontinence-Associated Dermatitis: An Insidious and Painful Condition

Cited by 2 publications

References 38 publications

Prognostic factors for the development of incontinence‐associated dermatitis (IAD): A systematic review

Prognostic factors for the development of incontinence‐associated dermatitis (IAD): A systematic review

What are the prognostic factors for the development of incontinence-associated dermatitis (IAD): a protocol for a systematic review and meta-analysis

Contact Info

Product

Resources

About